PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.95%
Negative revenue growth while MTDR stands at 15.60%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-18.89%
Negative gross profit growth while MTDR is at 10.22%. Joel Greenblatt would examine cost competitiveness or demand decline.
-41.45%
Negative EBIT growth while MTDR is at 12.13%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-41.45%
Negative operating income growth while MTDR is at 12.13%. Joel Greenblatt would press for urgent turnaround measures.
-55.65%
Negative net income growth while MTDR stands at 19.59%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-54.10%
Negative EPS growth while MTDR is at 18.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-54.10%
Negative diluted EPS growth while MTDR is at 22.58%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-4.20%
Share reduction while MTDR is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.20%
Reduced diluted shares while MTDR is at 0.06%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.21%
Dividend growth of 0.21% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-16.56%
Negative OCF growth while MTDR is at 17.28%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
21.79%
Positive FCF growth while MTDR is negative. John Neff would see a strong competitive edge in net cash generation.
-72.63%
Negative 10Y revenue/share CAGR while MTDR stands at 909.95%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-54.13%
Negative 5Y CAGR while MTDR stands at 56.56%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
23.99%
3Y revenue/share CAGR under 50% of MTDR's 152.09%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-84.08%
Negative 10Y OCF/share CAGR while MTDR stands at 547.52%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-39.15%
Negative 5Y OCF/share CAGR while MTDR is at 49.13%. Joel Greenblatt would question the firm’s operational model or cost structure.
163.69%
3Y OCF/share CAGR similar to MTDR's 171.01%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
238.41%
Net income/share CAGR at 50-75% of MTDR's 470.39%. Martin Whitman might question if the firm’s product or cost base lags behind.
-97.03%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-69.51%
Negative 3Y CAGR while MTDR is 194.93%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-77.43%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-41.49%
Negative 5Y equity/share growth while MTDR is at 37.94%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
3.28%
Below 50% of MTDR's 229.18%. Michael Burry suspects a serious short-term disadvantage in building book value.
-95.46%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-73.64%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
19.77%
3Y dividend/share CAGR of 19.77% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-4.75%
Firm’s AR is declining while MTDR shows 25.83%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-1.80%
Negative asset growth while MTDR invests at 4.94%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.40%
75-90% of MTDR's 3.84%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-1.05%
We’re deleveraging while MTDR stands at 2.05%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-2.84%
We cut SG&A while MTDR invests at 2.54%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.